Orchestra BioMed | 10-Q:2024财年三季报
Orchestra BioMed | SC 13G:超过5%持股股东披露文件-BlackRock, Inc.(5.1%)
Orchestra BioMed | SC 13G:超过5%持股股东披露文件-BlackRock, Inc.(5.1%)
Orchestra BioMed | 4:持股变动声明-高管 Hochman David P
Orchestra BioMed | 4:持股变动声明-高管 Sherman Darren
Orchestra BioMed | 4:持股变动声明-董事 Fain Eric S
Orchestra BioMed | 144:拟议出售证券
Orchestra BioMed | 144:拟议出售证券
Orchestra BioMed | 144:拟议出售证券
Orchestra BioMed | 144:拟议出售证券
Orchestra BioMed | 4:持股变动声明-高管 Sherman Darren
Orchestra BioMed | 144:拟议出售证券
Orchestra BioMed | 144:拟议出售证券
Orchestra BioMed | 144:拟议出售证券
Orchestra BioMed | 144:拟议出售证券
Orchestra BioMed | 4:持股变动声明-高管 Hochman David P
Orchestra BioMed | 8-K:重大事件
Orchestra BioMed | 424B5:募资说明书
Orchestra BioMed | 10-Q:2024财年二季报
Orchestra BioMed | 4:持股变动声明-董事 Mack John Prosper
暂无数据
暂无数据